BioCryst Pharmaceuticals(BCRX) - 2025 Q3 - Earnings Call Presentation
Third Quarter 2025 Results Call Corporate Update & Financial Results November 3, 2025 CONFIDENTIAL & PROPRIETARY Forward-looking statements This presentation contains forward-looking statements, including statements regarding, among other things, future results, performance or achievements, expectations regarding pipeline development, the expected benefits of BioCryst's acquisition of Astria (the "Merger") and BioCryst's ability to recognize the benefits of the Merger, expected Merger consideration, the ant ...